GTC 7th Diabetes Drug Discovery and Development Conference

Complications of Type 2 Diabetes: Diabetic Dyslipidemia and NASH and potential of MGL-3196, a Phase 2 ready liver targeted thyroid receptor beta agonist
April 23-25, 2014 | Cambridge, MA